S-allylcysteine Improves Blood Flow Recovery and Prevents Ischemic Injury by Augmenting Neovasculogenesis

Studies suggest that a low level of circulating human endothelial progenitor cells (EPCs) is a risk factor for ischemic injury and coronary artery disease (CAD). Consumption of S-allylcysteine (SAC) is known to prevent CAD. However, the protective effects of SAC on the ischemic injury are not yet cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Syu, Jia-Ning, Yang, Mei-Due, Tsai, Shu-Yao, Chiang, En-Pei Isabel, Chiu, Shao-Chih, Chao, Che-Yi, Rodriguez, Raymond L., Tang, Feng-Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753981/
https://www.ncbi.nlm.nih.gov/pubmed/29251114
http://dx.doi.org/10.1177/0963689717724792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753981/
https://www.ncbi.nlm.nih.gov/pubmed/29251114
http://dx.doi.org/10.1177/0963689717724792

Ejemplares similares